Anlotinib as a molecular targeted therapy for tumors

Y Gao, P Liu, R Shi - Oncology Letters, 2020 - spandidos-publications.com
… of anlotinib were summarized with a focus on safety evaluation … of anlotinib are summarized
and, more importantly, the safety … use of anlotinib for cancer treatment are fully described. …

Efficacy and safety of anlotinib combined with liposomal doxorubicin followed by anlotinib maintenance in metastatic soft tissue sarcomas

Z Liu, W Yao, Y Zhao, O Liu, P Zhang… - Cancer Management and …, 2021 - Taylor & Francis
Anlotinib is a novel tyrosine kinase inhibitor with promising anti-tumor activity in patients with
efficacy and safety of anlotinib combined with liposomal doxorubicin followed by anlotinib

Clinical investigation of the efficacy and safety of anlotinib with immunotherapy in advanced non-small cell lung cancer as third-line therapy: a retrospective study

S Yang, W Zhang, Q Chen, Q Guo - Cancer Management and …, 2020 - Taylor & Francis
… In this study, we evaluated the efficacy of anlotinib combined with immunotherapy in 101
patients with advanced NSCLC. Our short-term efficacy analysis of these data showed that 19 …

Safety and efficacy of chemotherapy combined with anlotinib plus anlotinib maintenance in Chinese patients with advanced/metastatic soft tissue sarcoma

H Wang, J Chu, P Zhang, J Wang, Z Yan… - OncoTargets and …, 2020 - Taylor & Francis
Anlotinib, a newly developed oral small-molecule receptor tyrosine kinase inhibitor (TKI), …
evaluate the safety and clinical efficacy of chemotherapy combined with anlotinib plus anlotinib

Efficacy and safety of anlotinib combined with PD‐1/PD‐L1 inhibitors as second‐line and subsequent therapy in advanced small‐cell lung cancer

L Yu, J Xu, R Qiao, B Han, H Zhong… - Cancer Medicine, 2023 - Wiley Online Library
… We explored the efficacy and safety of combination therapy with anlotinib and programmed
cell death protein 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) inhibitors as second-line …

The efficacy and safety of anlotinib in neoadjuvant treatment of locally advanced thyroid cancer: a single-arm phase II clinical trial

N Huang, W Wei, J Xiang, J Chen, Q Guan, Z Lu, B Ma… - Thyroid, 2021 - liebertpub.com
… We aimed to evaluate the efficacy and safety of anlotinib in … II study investigated the efficacy
and safety of anlotinib (12 mg … aimed to evaluate the efficacy and safety of anlotinib in locally …

Efficacy and safety of anlotinib in patients with unresectable or metastatic bone sarcoma: A retrospective multiple institution study

Z Liu, S Gao, L Zhu, J Wang, P Zhang, P Li… - Cancer …, 2021 - Wiley Online Library
… This retrospective study aims to analyze the safety and efficacy of anlotinib, a novel multi‐target
TKI, in patients with locally unresectable or metastatic bone sarcoma at three institutions. …

Efficacy and safety of anlotinib for elderly patients with previously treated extensive-stage SCLC and the prognostic significance of common adverse reactions

PF Song, N Xu, Q Li - Cancer Management and Research, 2020 - Taylor & Francis
… regarding the efficacy of … efficacy of patients who were treated with anlotinib was necessary.
Citation21 The aim of the present study was to investigate the efficacy and safety of anlotinib

Efficacy and safety of anlotinib-containing regimens in advanced non-small cell lung cancer: a real-world study

L Sun, Q Zhao, Y Wang, Y Wang, M Zheng… - … Journal of General …, 2023 - Taylor & Francis
… -world efficacy and safety of anlotinib-containing … , efficacy and safety of anlotinib in real-world
clinical applications, and conducted subgroup analysis to compare the efficacy of anlotinib

[HTML][HTML] Efficacy and safety of anlotinib as an adjuvant therapy in hepatocellular carcinoma patients with a high risk of postoperative recurrence

J Wang, X Xiang, Z Shi, H Zhang, Q Zhang… - Chinese Journal of …, 2023 - ncbi.nlm.nih.gov
… This study aims to investigate the efficacy and safety of anlotinib in … However, the clinical
application of anlotinib in the … aim to evaluate the efficacy and safety of anlotinib in postoperative …